Home › Trial NCT04050462
Nivolumab Combined With BMS-986253 in HCC Patients
- Trial IDNCT04050462
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorNYU Langone Health
- Enrollment13
- Start date2019-09-12
- ConditionsHepatocellular Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.